Takeaway FDA approval for a GLP-1 drug to treat sleep apnea could come soon, some analysts predict
These systems demonstrate superiority in topical anti-inflammatory, antimicrobial, and antihypertensive therapies through increased cutaneous drug deposition (Kumar and Utreja, 2020)
Often chosen, this approach is speedier and more easily observable
More recently, a family of potent and highly selective mechanism-based suicide substrate inhibitors were developed and shown to promote the irreversible inhibition of gut microbiotadependent generation of TMA, suppression of host TMAO levels, and, in parallel, inhibition of platelet hyperresponsiveness and thrombosis potential in animal models (22)
The most appropriate GLP-1RA to use will ultimately be dictated by the device and how it aligns with the patients needs, as well as associated costs and the reimbursement status of the drug options
Stop use and seek emergency care if you have hives, swelling of face/lips/tongue/throat, or trouble breathing